SPY335.57+1.00 0.30%
DIA278.14+3.52 1.28%
IXIC10,968.36-42.63 -0.39%

Emergent BioSolutions Q2 EPS $1.73 May Not Compare To $0.64 Estimate, Sales $394.70M Beat $294.73M Estimate

Emergent BioSolutions (NYSE:EBS) reported quarterly earnings of $1.73 per share which beat the analyst consensus estimate of $0.64 by 170.31 percent. This is a 1541.67 percent increase over losses of $(0.12) per share

Benzinga · -
Emergent BioSolutions (NYSE: EBS) reported quarterly earnings of $1.73 per share which beat the analyst consensus estimate of $0.64 by 170.31 percent. This is a 1541.67 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $394.70 million which beat the analyst consensus estimate of $294.73 million by 33.92 percent. This is a 62.29 percent increase over sales of $243.20 million the same period last year.